SHZ · Financial Statements

Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) Financial Statements

$4.85 SHZ: 300239.SZ Market Cap $2.93B

Full income statement, balance sheet, and cash flow statement for Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio14.32
EV / EBITDA19.86
FCF Yield—
Quick Ratio2.73
Interest Coverage—
Return 1Y-14.56%
Return 3Y-21.27%
Return 5Y-18.26%

Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) financials — frequently asked questions

What is 300239.SZ EV/EBITDA?

Baotou Dongbao Bio-Tech Co.,Ltd's enterprise value to EBITDA (EV/EBITDA) ratio is 19.86.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
300239.SZ Overview 300239.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.